A comparison of glyburide and insulin in women with gestational diabetes mellitus

New England Journal of Medicine

Volumn 343, Issue 16, 2000, Pages 1134-1138

  Langer, Oded ^a   Conway, Deborah L ^b   Berkus, Michael D ^b   Xenakis, Elly M J ^b   Gonzales, Olga ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; FEMALE; FETUS MALFORMATION; GESTATIONAL AGE; HIGH BIRTH WEIGHT; HUMAN; HYPOGLYCEMIA; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; TERATOGENICITY; TREATMENT OUTCOME;

ABNORMALITIES; ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; FETAL BLOOD; FETAL MACROSOMIA; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; PREGNANCY; PREGNANCY OUTCOME;

EID: 0034687440     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200010193431601     Document Type: Article

References (49)

1. Intensified versus conventional management of gestational diabetes
2. Diabetes and pregnancy
3. Gestational diabetes mellitus
4. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes
5. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy
6. Insulin secretagogues: Old and new
7. Hypoglycemia in newborn infants of normal and diabetic mothers
8. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy
9. Teratogenic effects of chlorpropamide in mouse embryos in vitro
10. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis
11. Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro
12. Use of chlorpropamide in the treatment of diabetes in pregnancy
13. Tolbutamide and chiorpropamide during pregnancy in human diabetics
14. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome
15. Oral hypoglycaemics in the first trimester and fetal outcome
16. Pregnancy in established non-insulin-dependent diabetics a five-and-a-half year study at Groote Schuur Hospital S Afr Med J
17. Oral hypoglycaemic therapy in diabetic pregnancies
18. The diagnostic and therapeutic value of tolbutamide in pregnant diabetics
19. Sulfonylurea drugs in pregnancy
20. Sulphonylurea therapy in the treatment of the pregnant diabetic
21. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy
22. Chlorpropamide in diabetic pregnancy
23. Chlorpropamide and perinatal mortality
24. The management of non-insulin-dependent diabetes during pregnancy
25. Metformin in management of pregnant insulin-dependent diabetics
26. Effects of in-utero exposure to oral hypoglycaemic drugs
27. Sulphonylureas in pregnancy
28. Oral hypoglycemic agents
29. Insignificant transfer of glyburide occurs across the human placenta
30. Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer
31. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin
32. Criteria for screening tests for gestational diabetes
33. Gestational diabetes: Insulin requirements in pregnancy
34. Rationale for insulin management in gestational diabetes mellitus
35. Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus
36. Diabetes in pregnancy: Evaluating self-monitoring performance and glycemic control with memory-based reflectance meters
37. Glycemic control in gestational diabetes mellitus - How tight is tight enough: Small for gestational age versus large for gestational age?
38. The large fetus
39. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial
40. Effect of exogenous arachidonic acid and enzyme inhibitors on placental prostanoid production
41. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography
42. High-performance liquid chromatographic determination of glibenclamide in human plasma and urine
43. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound
44. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects
45. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans
46. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals
47. Glucose toxicity
48. Mechanism of improvement in glucose metabolism after chronic glyburide therapy
49. Glyburide crosses the placenta in vivo in pregnant rats